API | l-carnosine

l-carnosine Report issue

Small molecule Experimental

AACT DrugBank PubChem

Active Ingredient History

NOW

Carnosine (beta-alanyl-L-histidine) is a dipeptide molecule, made up of the amino acids beta-alanine and histidine. It is highly concentrated in muscle and brain tissues. Carnosine was discovered by Russian chemist Vladimir Gulevich. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

carnosine | l-carnosine

Organizations (24)

Research & Development (24)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (10)

Approved Indications (1)

Diabetes Mellitus, Type 2

Experimental Indications - Clinical Trial Phases 1-4 (9)

Cognition Disorders (Phase 2)

Glycemic Control (Phase 2)

Heart Disease Risk Factors (Phase 2)

Hyperuricemia (Phase 4)

Neoplasms (Phase 1/Phase 2)

Peripheral Arterial Disease (Phase 2)

Peripheral Nervous System Diseases (Phase 1/Phase 2)

Persian Gulf Syndrome (Phase 2)

Schizophrenia (Phase 2/Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 21
# of Trial Organizations: 24

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue